This insider cluster is routine and non-informational — the sales are tied to option exercises and tax withholding, not a bearish signal. Monitor for any upcoming earnings or pipeline updates, but this filing alone does not warrant a trading action.
Price Chart
Executive Summary
A cluster of insider sales at United Therapeutics shows the CEO and General Counsel selling shares, primarily to cover tax obligations from exercised options. The total open-market sales of ~$349K represent a trivial 0.0015% of the $22.7B market cap, making this a routine, non-informational event. Historical calibration data suggests prior neutral-scored reports on UTHR have underperformed, but this filing's content does not warrant a directional call.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold ~$4.5M in open-market shares on July 17, 2026, but these were part of a larger option exercise (9,500 shares at $0) and a cash exercise (9,500 shares at $135.42), with the sales primarily covering tax withholding.
- EVP Paul Mahon sold ~$1.8M in open-market shares on July 16, 2026, also tied to option exercises (8,300 shares at $146.03 and 8,300 shares at $0).
- Director Jan Malcolm sold $179K in open-market shares on July 10, 2026, a standalone sale not linked to option exercises.
- Total open-market sales in the cluster are ~$349K, which is 0.0015% of UTHR's $22.7B market cap — a trivial amount.
- The 30-day insider activity shows 9 sells totaling $4.8M, consistent with routine option exercise and tax-related selling patterns.
Financial Impact
Total open-market sales of ~$349K, representing 0.0015% of market cap. No material financial impact.
Risk Factors
- Insider selling patterns could intensify if the stock continues to appreciate, but current volume is trivial.
- No material risk identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1784613717929 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access